EdwardFMcClayMD

PubMed

• An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
  Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Bu...> ;CNS Oncology. 2023 Sep 1
• 71 citations
  Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies.
  Julius Strauss, Margaret E. Gatti-Mays, Byoung Chul Cho, Andrew G. Hill, Sébastien Salas, Edward F. McClay, Jason M. Redman, Houssein Abdul Sater, Renee N. Donahue, Ca...> ;Journal for Immunotherapy of Cancer. 2020 Dec 1
• 14 citations
  Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
  Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, Franklin Chen, Karen Kelly, Janice M. Mehnert, John C....> ;Journal for Immunotherapy of Cancer. 2020 Sep 1
• 46 citations
  Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort.
  Byoung Chul Cho, Amaury Daste, Alain Ravaud, Sébastien Salas, Nicolas Isambert, Edward F. McClay, Ahmad Awada, Christian Borel, Laureen S. Ojalvo, Christoph Helwig, P....> ;Journal for Immunotherapy of Cancer. 2020 Jul 1
• 40 citations
  PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in ope...
  Daniel P. Petrylak, Nicholas J. Vogelzang, Kamal Chatta, Mark D. Fleming, David Smith, Leonard Joseph Appleman, Arif Hussain, Manuel Modiano, Parminder Singh, Scott T....> ;The Prostate. 2020 Jan 1
• 23 citations
  First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
  Boris Minev, Elliot B Lander, John Feller, Mark Berman, Bernadette Greenwood, Ivelina Minev, Antonio F. Santidrian, Duong Nguyen, Dobrin Draganov, Mehmet O. Killinc, A...> ;Journal of Translational Medicine. 2019 Aug 19
• 6 citations
  Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
  Robert O Dillman, Andrew N. Cornforth, Edward F. McClay, Carol DePriest> ;Melanoma Management. 2019 May 31
• 39 citations
  Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
  Daniel P. Petrylak, Philip W. Kantoff, Nicholas J. Vogelzang, Anthony Mega, Mark D. Fleming, Joe Stephenson, Richard Frank, Neal D. Shore, Robert Dreicer, Edward F. Mc...> ;The Prostate. 2019 May 1
• 8 citations
  An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
  Charles Cobbs, Edward McClay, J. Paul Duic, L. Burt Nabors, Donna Morgan Murray, Santosh Kesari> ;CNS Oncology. 2019 Mar 1
• 38 citations
  Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
  Robert O. Dillman, Andrew N. Cornforth, Gabriel Nistor, Edward F. McClay, Thomas Amatruda, Carol DePriest> ;Journal for Immunotherapy of Cancer. 2018 Mar 6
• 4 citations
  Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
  Daruka Mahadevan, Monica M. Mita, Donald A. Richards, Edward McClay, Rebecca S. Heist, Abhijeet Kumar, Srinath Sundararajan, Aung Naing> ;Cancer Chemotherapy and Pharmacology. 2017 Mar 13
• 18 citations
  Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent ...
  Robert O. Dillman, Edward F. McClay, Neil M. Barth, Thomas Amatruda, Lee S. Schwartzberg, Khosrow Mahdavi, Cristina de Leon, Robin E. Ellis, Carol DePriest> ;Cancer Biotherapy & Radiopharmaceuticals. 2015 Jun 1
• 38 citations
  Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients
  Carmen Ruiz, Julia Li, Madelyn Luttgen, Anand Kolatkar, Jude Kendall, Edna Flores, Zheng Z. Topp, Wolfram E Samlowski, Edward McClay, Kelly Bethel, Soldano Ferrone, Ja...> ;Physical Biology. 2015 Jan 9
• 56 citations
  Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic ...
  Robert O. Dillman, Andrew N. Cornforth, Carol DePriest, Edward F. McClay, Thomas Amatruda, Cristina de Leon, Robin E. Ellis, Cheryl Mayorga, Denysha Carbonell, James M...> ;Journal of Immunotherapy. 2012 Oct 1
• Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: are there safe and potentially effective treatments?
  Kendra J. Feeney, Henry C. Maguire, Edward F. McClay, Takami Sato, Vernon K. Sondak, Mary Toporcer, Jonathan S. Zager> ;Seminars in Oncology. 2010 Aug 1
• The role of anti-tumor necrosis factor receptor agents in cancer survivors revisited.
  Edward F. McClay> ;Seminars in Oncology. 2010 Jun 1
• 19 citations
  Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting
  Elizabeth B. Lamont, Mary Beth Landrum, Nancy L. Keating, Laura Archer, Lan Lan, Gary M. Strauss, Rogerio Lilenbaum, Harvey B. Niell, L. Herbert Maurer, Michael P. Kos...> ;Journal of Clinical Oncology. 2010 Jan 10
• 2 citations
  Completely regressed cutaneous melanocytic lesion: was it benign or was it malignant?
  Adam C. Berger, Edward F. McClay, Mary Toporcer, Gloria J. Morris> ;Seminars in Oncology. 2009 Oct 1
• 52 citations
  Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with...
  Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz, Edward F. McClay, Neil M. Barth, Carol DePriest, Cristina de Leon, Cheryl Mayorga, Andrew N. Cornforth, Kano...> ;Cancer Biotherapy & Radiopharmaceuticals. 2009 Jun 19
• 8 citations
  Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.
  Jeffrey A. Bogart, Dorothy Watson, Edward F. McClay, Lisa Evans, James E. Herndon, F. Laurie, Stephen L. Seagren, Thomas J. Fitzgerald, Everett E. Vokes, Mark R. Green> ;Lung Cancer. 2008 Oct 1
• A phase I/II trial of the combination of bevacizumab, oxaliplatin, and sorafenib in patients with metastatic melanoma.
  McClay EF, Bessudo A, Frakes L, Eisenberg S, Just R, Banerjee P, Sinclair J> ;J. Clin. Oncol.. 2008-05-20
• 4 citations
  Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases
  Alireza Mirmiran, Edward McClay, Matthew A Spear> ;Medical Oncology. 2007 Jan 1
• 35 citations
  A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung ca...
  Edward F. McClay, Jeff Bogart, James E. Herndon, D. M. Watson, Lisa Evans, Steven L. Seagren, Mark R. Green> ;American Journal of Clinical Oncology. 2005 Feb 1
• 37 citations
  Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: Planned interim analysis
  Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz, Cheryl Peterson, Kanoe Allen, Carol DePriest, Edward F. McClay, Neil M. Barth, Patric Sheehy, Cristina de Le...> ;Cancer Biotherapy & Radiopharmaceuticals. 2004 Nov 15
• Pure autologous tumor cells (TC) and dendritic cells (DC) with GM-CSF: Patient-specific vaccine for metastatic melanoma.
  Dillman RO, Selvan SR, Schiltz PM, Allen K, Depriest C, McClay EF, Barth NM, Sheehy PF, De Leon C, Peterson C> ;J. Clin. Oncol.. 2004-07-15
• Join now to see all